Group 2H: Triple Negative Breast Cancer; Ethnic/Racial Outcomes & Disparities

Wednesday, Dec 14
2:00 pm – 3:30 pm Eastern Time (US/New York)

Poster #PD1-10

Impact of race on clinical, socioeconomic, and genomic characteristics, clinical trial participation, and receipt of genotype-matched therapy among patients with metastatic breast cancer

Poster author Neelima Vidula, M.D. will attend this session

Poster #P1-06-02:

The effect of race on pathologic complete response rates and overall survival in patients with triple negative breast cancer

Mentor: Barbara Segarra-Vazquez

Bárbara Segarra-Vázquez, D.H.Sc., has been a faculty member at the University of Puerto Rico for more than 30 years, was the Dean of the School of Health Professions for seven years, and is the Principal Investigators of a R25 training program for young investigators funded by NIMHD (R25MD007607). She is a two-time breast cancer survivor and is very active as a research advocate. One of her main focuses is to increase diversity in clinical trials. She is a member of SWOG Cancer Network Patient Advocates Committee and the Cancer Care Delivery Committee. She serves on the Patient Advisory Committee for ASCO’s Cancer LinQ, and is the Chair of the Susan G. Komen Advocates in Science Steering Committee. She is also a member of the External Advisory Panel for the Participant Engagement and Cancer Genome Sequencing (PE-CGS) Network. She has served several times as a consumer reviewer for the Breast Cancer Research Program of the Department of Defense.

Twitter: @barbarasegarra

Scientist: Aileen Fernandez, Ph.D.

Aileen Fernandez’s postdoctoral research is in translational oncology and focuses on identifying and developing biomarkers to better identify which patients with cancer will respond to targeted therapies, improving patient care. Aileen completed her PhD in the Tumor Biology training program at Georgetown University (GU) in 2019. While there, she worked in the laboratory of Dr. Rebecca B. Riggins and focused on triple negative breast cancer, an aggressive breast cancer subtype that disproportionally affects African-American women and lacks targeted therapies. While at GU, Aileen co-founded the Women in Science and Education (WISE) group with her colleagues, serving as the group’s strategist, secretary, and diversity liaison.

Aileen is passionate about leveling accessibility in science and promoting diversity, equity, and inclusion. She also strongly believes in improving science communication to better disseminate information from the scientists’ bench to society.

Twitter: @AileenIlianaPhD